![Calveley Peter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Calveley Peter
Directeur des opérations chez
Westlake Biopartners LLC
Profil
Calveley Peter is currently the Chief Operating Officer at Westlake Biopartners LLC since 2021.
Prior to this, he worked as a Managing Director at Leerink Partners LLC from 2010 to 2019.
Mr. Peter completed his undergraduate degree from Queen's University in 2001 and received an MBA from UCLA Anderson School of Management in 2007.
Postes actifs de Calveley Peter
| Sociétés | Poste | Début |
|---|---|---|
Westlake Biopartners LLC
 Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Directeur des opérations | 01/02/2021 |
Anciens postes connus de Calveley Peter
| Sociétés | Poste | Fin |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Directeur/Membre du Conseil | 30/09/2019 |
Formation de Calveley Peter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Westlake Biopartners LLC
Westlake Biopartners LLC Investment ManagersFinance Westlake Biopartners invests in companies located in the United States. The firm focuses on life sciences sectors. It participates in early and later stage capital requirements. | Finance |
